Depression, Fatigue, Gulf War, Pain
Conditions
Keywords
pain management, fatigue, mindfulness, Gulf War
Brief summary
This study is a randomized clinical trial measuring outcomes up to 6-months post-intervention. The objective of this study is to evaluate outcomes of two different group interventions for Veterans with Chronic Multisymptom Illness (CMI). The interventions to be compared are Mindfulness-Based Stress Reduction and an adapted version of the Chronic Disease Self-Management Program (aCDSMP) for Veterans experiencing symptoms of Chronic Multi-Symptom Illness (CMI) - musculoskeletal pain, fatigue, and cognitive failures - especially those who were deployed to Gulf War I. Hypothesis One (re: Outcomes): Participants randomized to the adapted Chronic Disease Self-Management Program (aCDSMP) will derive benefit for the primary outcomes, but with smaller effects than the participants randomized to Mindfulness-Based Stress Reduction (MBSR). The investigators hypothesize that Veterans randomized to MBSR will report greater reductions in each of the three primary outcome measures (pain, fatigue, and cognitive failures) at 6-month follow-up as compared to aCDSMP. Hypothesis Two (re: Acceptability): MBSR will be an acceptable and satisfactory program for Veterans with CMI, as measured by attendance rates, a self-report measure of satisfaction, and qualitative interviews. The investigators hypothesize that Veterans with CMI randomized to MBSR will report greater satisfaction with care than their peers randomized to aCDSMP.
Detailed description
The investigators will enroll 308 participants. Half of these will be Gulf War Veterans who meet criteria for CMI, and the other half will be Veterans from other periods of service who also meet criteria for CMI. Each participant will be randomized to either participate in MBSR or aCDSMP (stratified by Gulf War deployment status so there are \ 7-8 Gulf War Veterans in each group for every cohort). Measures to collect primary outcome data (pain, fatigue, cognitive failures, patient satisfaction), secondary outcomes, and potential mediators will be administered at four assessments: (1) Baseline; (2) Post-Intervention; (3) at 3-months after the group ended; and (4) at 6-months after the group ended. Sample demographic data (age, gender, race, income, education, etc.) will be collected at baseline only. All study procedures will take place at VA Puget Sound Health Care System in Seattle, WA.
Interventions
An 8-week standardized group program to teach mindfulness skills. In MBSR, participants meet for 2.5 hours per week for 8 weeks in a group format. Participants receive instruction in mindfulness meditation according to a standardized curriculum and have the opportunity to ask questions.
The CDSMP is a structured program to teach self-management skills based on self-efficacy theory. CDSMP teaches self-management strategies and attempts to modify illness beliefs, enhance self-management capabilities and reinforce successful management strategies. CDSMP is based on self-efficacy theory, which posits that key determinants of behavior are: 1). self-efficacy (confidence in the ability to carry out an action) and 2). outcome expectancy (expectation that a particular goal will be achieved).
Sponsors
Study design
Eligibility
Inclusion criteria
* Self-report all the criteria for Chronic Multi-Symptom Illness * Fluent in English and able to provide informed consent
Exclusion criteria
* Currently drinking with past-year history of alcohol-related seizures or delirium tremens * Current DMS-V substance use disorder other than cannabis or nicotine * Moderate or high risk of suicide as assessed with MINI * Current psychotic disorder * Current manic episode * Diagnosis of borderline personality disorder or antisocial personality disorder * Inpatient admittance for psychiatric reasons in the past month * Prior participation in MBSR or CDSMP (attended at least one session)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Client Satisfaction Questionnaire (CSQ-8) | report at post-intervention assessment, 3-4 months after baseline | A measure of satisfaction with the interventions. Minimum value: 8, maximum value: 32, higher scores indicate higher satisfaction. |
| Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score | Change from baseline to 6 months after completing the intervention | A validated measure of pain, minimum value: 0, maximum value: 222, higher scores indicate worse outcomes. |
| General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI) | Change from baseline to 6 months after completing the intervention | A measure of general fatigue symptoms. Minimum value: 0, maximum value: 80, higher scores indicate worse outcomes. |
| Cognitive Failures Questionnaire (CFQ) | Change from baseline to 6 months after completing the intervention | A measure of concentration and memory disturbances. Minimum value: 0, maximum value: 100, higher scores indicate worse outcomes. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient Health Questionnaire (PHQ-9) | Change from baseline to 6 months after completing the intervention | A measure of depression. Minimum value: 0, maximum value: 27, higher scores indicate worse outcomes. |
| PTSD Checklist - Civilian Version (PCL-C) | Change from baseline to 6 months after completing the intervention | A measure of PTSD. Minimum value: 0, maximum value: 80. Higher score indicates worse outcome. |
| SF-12, Standard (Mental and Physical Component Summary Scores) | Change from baseline to 6 months after completing the intervention | A measure of functional status and wellbeing. Two scores generated: a mental component score (MCS) and a physical component score (PCS). For each measure: minimum value: 0, maximum value: 100. Lower score indicates worse outcome. |
| NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form | Change from baseline to 6 months after completing the intervention | Substance Use Disorder (SUD) symptom severity for alcohol. Minimum score: 0, maximum score: 35. Higher scores indicate worse outcomes. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited based off of direct mailings generated by a VINCI data pull and the Gulf War Registry, between July 2017 and December 2020. The first participant was enrolled on August 8, 2017, and the last participant was enrolled on December 30, 2020.
Pre-assignment details
Of 258 enrolled participants, 245 met inclusion criteria and were randomized to treatment.
Participants by arm
| Arm | Count |
|---|---|
| Mindfulness-Based Stress Reduction An 8-week standardized group program to teach mindfulness skills. In MBSR, participants meet for 2.5 hours per week for 8 weeks in a group format. Participants receive instruction in mindfulness meditation according to a standardized curriculum and have the opportunity to ask questions.
Mindfulness-Based Stress Reduction: An 8-week standardized group program to teach mindfulness skills. In MBSR, participants meet for 2.5 hours per week for 8 weeks in a group format. Participants receive instruction in mindfulness meditation according to a standardized curriculum and have the opportunity to ask questions. | 115 |
| Chronic Disease Self-Management Program The CDSMP is a structured program to teach self-management skills based on self-efficacy theory. CDSMP teaches self-management strategies and attempts to modify illness beliefs, enhance self-management capabilities and reinforce successful management strategies. CDSMP is based on self-efficacy theory, which posits that key determinants of behavior are: 1). self-efficacy (confidence in the ability to carry out an action) and 2). outcome expectancy (expectation that a particular goal will be achieved).
Chronic Disease Self-Management Program: The CDSMP is a structured program to teach self-management skills based on self-efficacy theory. CDSMP teaches self-management strategies and attempts to modify illness beliefs, enhance self-management capabilities and reinforce successful management strategies. CDSMP is based on self-efficacy theory, which posits that key determinants of behavior are: 1). self-efficacy (confidence in the ability to carry out an action) and 2). outcome expectancy (expectation that a particular goal will be achieved). | 114 |
| Total | 229 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Adverse Event | 1 | 0 |
| Overall Study | Lost to Follow-up | 15 | 15 |
| Overall Study | Withdrawal by Subject | 7 | 11 |
Baseline characteristics
| Characteristic | Chronic Disease Self-Management Program | Mindfulness-Based Stress Reduction | Total |
|---|---|---|---|
| Age, Continuous | 55.6 years STANDARD_DEVIATION 8.7 | 57.4 years STANDARD_DEVIATION 9.4 | 56.5 years STANDARD_DEVIATION 9.1 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 11 Participants | 9 Participants | 20 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 103 Participants | 106 Participants | 209 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Gulf-War Veteran Status | 43 Participants | 44 Participants | 87 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 1 Participants | 2 Participants |
| Race (NIH/OMB) Asian | 4 Participants | 1 Participants | 5 Participants |
| Race (NIH/OMB) Black or African American | 23 Participants | 30 Participants | 53 Participants |
| Race (NIH/OMB) More than one race | 17 Participants | 3 Participants | 20 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 2 Participants | 2 Participants | 4 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 12 Participants | 9 Participants | 21 Participants |
| Race (NIH/OMB) White | 55 Participants | 69 Participants | 124 Participants |
| Sex/Gender, Customized Gender Female | 18 Participants | 14 Participants | 32 Participants |
| Sex/Gender, Customized Gender Male | 95 Participants | 101 Participants | 196 Participants |
| Sex/Gender, Customized Gender Transgender | 1 Participants | 0 Participants | 1 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 123 | 0 / 122 |
| other Total, other adverse events | 2 / 123 | 0 / 122 |
| serious Total, serious adverse events | 0 / 123 | 0 / 122 |
Outcome results
Client Satisfaction Questionnaire (CSQ-8)
A measure of satisfaction with the interventions. Minimum value: 8, maximum value: 32, higher scores indicate higher satisfaction.
Time frame: report at post-intervention assessment, 3-4 months after baseline
Population: participants who completed at least 1 intervention session
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Mindfulness-Based Stress Reduction | Client Satisfaction Questionnaire (CSQ-8) | 25.7 score on a scale | Standard Deviation 5.5 |
| Chronic Disease Self-Management Program | Client Satisfaction Questionnaire (CSQ-8) | 26.1 score on a scale | Standard Deviation 4.6 |
Cognitive Failures Questionnaire (CFQ)
A measure of concentration and memory disturbances. Minimum value: 0, maximum value: 100, higher scores indicate worse outcomes.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | Cognitive Failures Questionnaire (CFQ) | Baseline | 47.0 score on a scale | Standard Deviation 18.6 |
| Mindfulness-Based Stress Reduction | Cognitive Failures Questionnaire (CFQ) | final 6-month post-intervention | 43.5 score on a scale | Standard Deviation 17.3 |
| Chronic Disease Self-Management Program | Cognitive Failures Questionnaire (CFQ) | Baseline | 49.5 score on a scale | Standard Deviation 15.3 |
| Chronic Disease Self-Management Program | Cognitive Failures Questionnaire (CFQ) | final 6-month post-intervention | 43.5 score on a scale | Standard Deviation 14.7 |
General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI)
A measure of general fatigue symptoms. Minimum value: 0, maximum value: 80, higher scores indicate worse outcomes.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on the measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI) | Baseline | 15.1 score on a scale | Standard Deviation 3.7 |
| Mindfulness-Based Stress Reduction | General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI) | final 6-month post-intervention | 14.2 score on a scale | Standard Deviation 4.1 |
| Chronic Disease Self-Management Program | General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI) | Baseline | 14.8 score on a scale | Standard Deviation 3.6 |
| Chronic Disease Self-Management Program | General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI) | final 6-month post-intervention | 13.6 score on a scale | Standard Deviation 4 |
Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score
A validated measure of pain, minimum value: 0, maximum value: 222, higher scores indicate worse outcomes.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on the measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score | Baseline | 69.2 score on scale | Standard Deviation 42.1 |
| Mindfulness-Based Stress Reduction | Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score | final 6-month post-intervention | 62.3 score on scale | Standard Deviation 43.4 |
| Chronic Disease Self-Management Program | Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score | Baseline | 64.9 score on scale | Standard Deviation 34.9 |
| Chronic Disease Self-Management Program | Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score | final 6-month post-intervention | 55.5 score on scale | Standard Deviation 38.7 |
NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form
Substance Use Disorder (SUD) symptom severity for alcohol. Minimum score: 0, maximum score: 35. Higher scores indicate worse outcomes.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on the measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form | Alcohol Negative Consequences Baseline | 4.1 score on a scale | Standard Deviation 5.7 |
| Mindfulness-Based Stress Reduction | NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form | Alcohol Negative Consequences final 6-month post-intervention | 4.7 score on a scale | Standard Deviation 6.2 |
| Chronic Disease Self-Management Program | NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form | Alcohol Negative Consequences Baseline | 4.5 score on a scale | Standard Deviation 5.5 |
| Chronic Disease Self-Management Program | NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form | Alcohol Negative Consequences final 6-month post-intervention | 5.2 score on a scale | Standard Deviation 5.6 |
Patient Health Questionnaire (PHQ-9)
A measure of depression. Minimum value: 0, maximum value: 27, higher scores indicate worse outcomes.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | Patient Health Questionnaire (PHQ-9) | final 6-month post-intervention | 7.8 score on a scale | Standard Deviation 6 |
| Mindfulness-Based Stress Reduction | Patient Health Questionnaire (PHQ-9) | Baseline | 9.8 score on a scale | Standard Deviation 5.9 |
| Chronic Disease Self-Management Program | Patient Health Questionnaire (PHQ-9) | Baseline | 9.7 score on a scale | Standard Deviation 5.9 |
| Chronic Disease Self-Management Program | Patient Health Questionnaire (PHQ-9) | final 6-month post-intervention | 7.1 score on a scale | Standard Deviation 5.7 |
PTSD Checklist - Civilian Version (PCL-C)
A measure of PTSD. Minimum value: 0, maximum value: 80. Higher score indicates worse outcome.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on the measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | PTSD Checklist - Civilian Version (PCL-C) | Baseline | 31.7 score on a scale | Standard Deviation 19 |
| Mindfulness-Based Stress Reduction | PTSD Checklist - Civilian Version (PCL-C) | final 6-month post-intervention | 28.8 score on a scale | Standard Deviation 20.5 |
| Chronic Disease Self-Management Program | PTSD Checklist - Civilian Version (PCL-C) | Baseline | 31.3 score on a scale | Standard Deviation 18.3 |
| Chronic Disease Self-Management Program | PTSD Checklist - Civilian Version (PCL-C) | final 6-month post-intervention | 30.3 score on a scale | Standard Deviation 18.1 |
SF-12, Standard (Mental and Physical Component Summary Scores)
A measure of functional status and wellbeing. Two scores generated: a mental component score (MCS) and a physical component score (PCS). For each measure: minimum value: 0, maximum value: 100. Lower score indicates worse outcome.
Time frame: Change from baseline to 6 months after completing the intervention
Population: Intent-to-treat population with complete data on the measure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | SF-12, Standard (Mental and Physical Component Summary Scores) | MCS Baseline | 40.3 score on a scale | Standard Deviation 11.5 |
| Mindfulness-Based Stress Reduction | SF-12, Standard (Mental and Physical Component Summary Scores) | MCS final 6-month post-intervention | 43.5 score on a scale | Standard Deviation 12.7 |
| Mindfulness-Based Stress Reduction | SF-12, Standard (Mental and Physical Component Summary Scores) | PCS Baseline | 24.7 score on a scale | Standard Deviation 8.8 |
| Mindfulness-Based Stress Reduction | SF-12, Standard (Mental and Physical Component Summary Scores) | PCS final 6-month post-intervention | 24.9 score on a scale | Standard Deviation 8.8 |
| Chronic Disease Self-Management Program | SF-12, Standard (Mental and Physical Component Summary Scores) | PCS final 6-month post-intervention | 25 score on a scale | Standard Deviation 8.3 |
| Chronic Disease Self-Management Program | SF-12, Standard (Mental and Physical Component Summary Scores) | MCS Baseline | 42.3 score on a scale | Standard Deviation 11.8 |
| Chronic Disease Self-Management Program | SF-12, Standard (Mental and Physical Component Summary Scores) | PCS Baseline | 23.4 score on a scale | Standard Deviation 7.8 |
| Chronic Disease Self-Management Program | SF-12, Standard (Mental and Physical Component Summary Scores) | MCS final 6-month post-intervention | 44.2 score on a scale | Standard Deviation 12.4 |